Purpose: Bladder cancer is a common malignancy, and a frequent cause of urological consul tation and surgical intervention. Except for smoking and certain occupational exposures, the etiology of bladder cancer is largely unknown* Although the majority of patients with bladder cancer do not have a family history of transitional cell carcinoma of the urinary tract, the study of familial transitional cell carcinoma may lead to knowledge of the pathogenesis of this disease.
Bladder cancer is the fourth most common tum or among white men in Western Europe and the United States, follow ing prostate, lung and colorectal cancer.1-3 In the U nited States the annual age adjusted incidence is 32/100,000 men and the lifetime risk of bladder cancer among white men is 3.6%. The annual age adjusted incidence among white women is 8/100,000.4 For undetermined reasons black men experience only half the risk of white men, whereas the risk for black women is essentially the same as th at for white women. 4 Of bladder cancers 95% are transitional cell tumors. Overall, bladder cancer constitutes the bulk of urothelial transitional cell neoplasms, with upper tract lesions contrib uting less than 1 0 % of all tumors arising from the urothelial cell surface.5 Numerous epidemiological studies have shown th at only smoking and certain occupational exposures (for example /3-naphthyl amine, benzidine and 4-aminobiphenyl) can be considered important environmental risk factors for bladder cancer development.6 Similar data are available for transitional cell carcinoma in the upper urinary tract, the only difference being phenacetin use, which was identified as an additional im portant risk factor. [7] [8] [9] [10] [11] Although attention has also been paid recently to genetic lesions hypothesized to contribute to transitional cell carci noma, the role of familial transmission has yet to be com pletely explored. Case reports suggest a familial component to bladder cancer. In addition, there is strong evidence for an increased risk of ureteral and renal pelvic transitional cell carcinoma in families with hereditary nonpolyposis colon cancer.12*13 We critically review the available d ata on fam il ial clustering of transitional cell carcinoma.
FAMILIAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER
Thelen and Schaeuble first reported familial clustering of transitional cell carcinoma in 1957, when they described identical male twins, both smokers, with "benign transitional cell papillomas" of the bladder.14 Fraum eni and Thomas re ported 4 cases of bladder cancer in a family of Russian-Jewish origin. 15 The father was diagnosed w ith invasive bladder cancer at age 54 years, and 3 sons had bladder cancer a t ages 57 and 64 years (2 had well differentiated noninvasive papillary tum ors and 1 had m etastatic squamous cell carcinoma). All affected individuals in this kindred were heavy smokers but none was employed in a high risk occu pation. The mother died of colon adenocarcinoma, In a fol io wup study of this family, 2 sons with bladder cancer la te r had primary lung cancers, 16 Benton and Henderson presented the occupational h isto ries of 9 individuals w ith transitional cell carcinoma of th e bladder diagnosed before age 25 years. 17 One patient w as a 19-year-old repairm an with exposure to glues and solvents. The father, a welder, was diagnosed with transitional cell carcinoma of the bladder 1 year before diagnosis in the son. Although chance occurrence is a possible explanation in this family, the young age at onset of disease strongly favors a hereditary etiology.
Familial bladder transitional cell carcinoma was also re- 20 The study is interesting because 5 of the 6 families were identified from a registration of 162 incident cases of bladder cancer, yielding a 3% prevalence estim ate of familial bladder cancer, and all 3 affected individuals in 1 family were diagnosed with dis ease at young ages (19, 28 and 33 years old, respectively). Mahboubi et al reported 3 cases of transitional cell carcinoma in a nuclear family. 21 Bladder cancer within a familial context is often seen in association with carcinomas of nongenitourinary origin. The association with retinoblastoma is especially noteworthy, Chan and P ratt described the family of an 1 1 -year-old white girl with bilateral retinoblastoma and multiple nonradiation induced osteosarcomas, 22 The m other had unilateral retino blastoma. The m aternal grandfather and 1 of his brothers were diagnosed w ith bladder transitional cell carcinoma at ages 60 and 47 years, respectively. Aherne described a family with retinoblastoma and osteosarcoma in which the mother of 2 affected children had bladder cancer at age 40 years. 23 Aherne also summarized 5 other British cases of retinoblas toma. The father of 1 patient died of bladder cancer at age 50 years. Although based on small numbers, subsequent studies confirmed the greater risk of bladder cancer among relatives of retinoblastoma patients. [24] [25] [26] This greater risk appeared to be confined to known carriers of the m utated retinoblastoma gene.
FAMILIAL TRANSITIONAL CELL CARCINOMA OF THE UPPER URINARY TRACT i
There are several cases of familial transitional cell carci noma of the upper urinary tract, the rarity of which favors a genetic origin. Some of these cases were reported before the risk of this tumor was suggested to be great in families with hereditary nonpolyposis colon cancer.12 Therefore, it is not always possible to evaluate whether familial transitional cell carcinomas of the ureter and renal pelvis occur in a site specific manner. Burkland and Juzek reported on a 6 8 -yearold white woman and her 53-year-old son, both of whom had transitional cell carcinoma of the right ureter.27 Her oldest sister died of intestinal cancer at age 60 years, Orphali et al described 3 siblings with transitional cell carcinoma of the upper urinary tract.28 Another sibling had cervical cancer and the father was diagnosed with lymphosarcoma a t a late age. Three paternal uncles, both grandfathers, 1 m aternal uncle and 1 m aternal aunt had unspecified cancers.
Other reports underscore the fact th at transitional cell carcinoma of the upper urinary tract may represent a signif icant expression of hereditary nonpolyposis colon cancer, [29] [30] [31] [32] [33] [34] [35] In the Japanese family reported on by Chiba et al the pro band was diagnosed with transitional cell carcinoma of the renal pelvis at age 49 years and she subsequently had endo metrial carcinoma a t age 50 years.33 The 3 brothers of this patient were diagnosed w ith colorectal cancer before age 45 years. One brother subsequently had transitional cell carci noma of the left u reter a t age 49 years and multiple bladder tumors at age 51 years. One brother had adenocarcinoma of the stomach and transitional cell carcinoma of the renal pelvis a t age 45 years. Greenland et al reported on 4 male siblings with transitional cell carcinoma, 3 of whom had renal pelvis cancer. 35 Two of the 4 siblings and 2 of their children had colorectal adenocarcinoma. A surprising detail in this report is th a t the fam ily came to attention after the wrong set of records was produced for 1 case. Before th a t time neither the patients them selves nor the urologist who treated 3 cases was aware of the fam ilial clustering.
The risk of transitional cell carcinoma is also reported to be greater in families w ith th e Muir-Torre syndrome, a rare autosomal dominant condition characterized by at least 1 sebaceous tumor and at least 1 visceral malignancy (predom inantly proximal colon cancer). The clinical features of this syndrome can overlap w ith those of hereditary nonpolyposis colon cancer. [36] [37] Fam ilies w ith the Muir-Torre syndrome have an increased risk of upper and lower urinary tract transitional cell carcinoma, in contrast to families with he reditary nonpolyposis colon cancer, in which there is no clear increased risk of bladder cancer,12'38*39
Another study suggests th a t familial transitional cell car cinoma of the upper u rin ary tract can occur in other settings. Marchetto et al reported on a 48-year-old woman with trans itional cell carcinoma of th e ureter who had endometrial cancer 2 years later.40 H er m other had transitional cell car cinoma of the ureter and renal cell carcinoma at age 57 years, and bladder cancer 3 years later. A 69-year-old cousin of the mother had transitional cell carcinoma of the bladder and ureter, and she was diagnosed with endometrial cancer 1 year previously. Four siblings of the mother had breast can cer, liver cancer, gastric adenocarcinoma and lung cancer. The m aternal grandfather died of a brain tum or at age 42 years. No colorectal tum ors were identified in this pedigree.
Strong familial clustering of transitional cell carcinoma of the upper and lower u rin ary tract has also been found in some rural areas of the B alkan states of eastern Europe. [41] [42] [43] It is likely th at the site specific familial clustering in these areas is related to B alkan endemic nephropathy and expo sure to environmental causes, such as ochratoxin A. 44 The high risk of transitional cell carcinoma among consanguine ous married persons and the low risk among relatives who moved to nonendemic villages strongly argue against a ge netic origin.
EPIDEMIOLOGICAL STUDIES
Case-control studies. A variety of studies have examined familial clustering of bladder cancer (see table) ,10*45-64 Most studies were small and used an ill-defined definition of fam ily history. However, 3 studies will be highlighted for differ ent reasons. The largest study is a population based exami nation of 2,982 patients and 5,782 controls conducted in 1978 (the United States national bladder cancer study).51 Of the cases 6% versus 4% of the controls identified a t least 1 member in the im m ediate family (that is parents and sib lings) who had genitourinary cancer. The odds ratio adjusted for race, sex, smoking and age was 1.5 (95% confidence in terval 1 .2 to 1 .8 ), which can be interpreted as a 50% greater risk of bladder cancer if th ere is a first degree relative with cancer of the genitourinary tract. This risk appeared to be somewhat greater in persons younger than 45 years (odds ratio 2.7, 95% confidence interval 0.8 to 2.9) and in female patients (odds ratio 1.8, 95% confidence interval 1.1 to 2.7). Unfortunately, examination of family history was not a major objective of this study. Therefore, the authors were unable to FAMILIAL TRANSITIONAL CELL CANCER
6 9
Case-coiitrol studies of transitional cell carcinoma in which fam ily history was evaluated distinguish bladder cancer from kidney cancer, for example, and were not able to verify reports of familial cancer. A later study acknowledged th at family history was not clearly as sociated with tumor stage and grade at diagnosis. 65 Piper et al performed a case-control study in young women, the group with a greater than average odds ratio for family history in the aforementioned United States national bladder cancer study.52 A total of 162 women with bladder cancer 2 0 to 49 years old was matched to population controls and asked about the history of bladder or kidney cancer (renal cell and transitional cell carcinoma) in first degree relatives. Four patients (2 .5 %) and 1 control subject (0 .6 %) reported a posi tive family history, yielding an insignificant odds ratio of 4.0. Only 1 individual reported bladder cancer in a parent, and 1 reported th a t a sister had papillary cancer of the kidney and ureter. The remaining 2 patients and 1 control subject re ported kidney cancer in the father. Thus, there is a striking difference between the prevalence of a positive history in this study and th a t in the United States national bladder cancer study. Of course, young women usually have young relatives with a low risk of bladder cancer. However, in the national bladder cancer study the prevalence was also much greater among female controls only (3.3%) and among con trols younger than 45 years (2.0%). The reason for this dif ference remains unknown.
In a German study conducted by Kunze et al 675 cases of histologically confirmed benign or malignant epithelial tu mors of the bladder, ureters, renal pelves and urethra were compared to matched controls with nonneoplastic diseases of the lower urinary tract (predominantly prostatic hyperplasia in men and urinary tract infection in women). 56 An in te r viewer administered questionnaire noted bladder cancer in first degree relatives. In a m ultivariate analysis, controlling for smoking status, occupational exposures and phenacetin use, a positive family history showed an odds ratio of 2.5 (95% confidence interval 1.1 to 5.8) in men and a statistically insignificant odds ratio of 1.5 in women. This greater risk in men is in contrast with the findings from the United States national bladder cancer study.52
Other epidemiological studies. A disadvantage of the afore mentioned case-control studies is th a t the exposure (bladder cancer in the family) was examined by simple questions asked the patients and controls. No adjustm ent could be made for total num ber of relatives, age, sex, smoking statu s and age of the relatives at cancer diagnosis. However, 1 study specifically addressed the issue of familial bladder cancer, and collected demographic data and cigarette smoking statu s on all first degree relatives of 319 m en with bladder cancer diagnosed in New York State and 319 neighborhood con trols.66 The 2 cohorts of relatives were then linked to the New York State Tumor Registry to obtain valid data on cancer occurrence. A total of 14 cases of bladder cancer was found among 1,619 relatives of patients and 7 were found among 1,773 relatives of controls, In a m ultivariate proportional hazards regression model w ith age, sex and smoking status, the hazard ratio of case-control status was 1.9 (90% confi dence interval 0.9 to 4.1). According to the authors, there were no instances in which more th an 1 first degree relative within a family was affected. Thus, the prevalence of a pos itive family history among the controls can be estim ated at 2 .2 %.
In a small hospital based study by Lynch et al the cumu lative risk of bladder cancer among first and second degree relatives of 49 consecutively ascertained bladder cancer cases was compared to the expected risk based on the United States third national cancer survey,67 The cumulative risk among relatives of the patients was 1.63 times greater than expected. The same comparison was made for the relatives of 3 other cancer groups (254 patients with lung cancer, 138 with other smoking related cancers and 564 with nonsmok ing related cancers). The risk for the relatives of these pa tients was not increased. This finding supports a nonenvironmental cause of familial clustering. In an additional analysis the authors found significant heterogeneity of risk across families, and only 3 of the 49 families studied (6 %) were at high risk. In contrast, in a study of Danish twins no differences were found between the concordance rate of u ri nary system cancers in 1,528 monozygotic twin pairs and in 2,609 same sexed, dizygotic twin p airs,68 In fact, in neither group was a pair w ith both twins affected found. This result has been used as an argum ent against a hereditary subtype of bladder cancer. However, the concordance rates of breast cancer and intestinal tumors (for which hereditary forms are known to exist) were also not greater in monozygotic twins.
Skolnick et al, 69 and Bishop and Skolnick70 presented the mean kinship coefficients of Mormon descendants registered in the Utah population based cancer registry. The kinship coefficient, which expresses the probability th a t randomly selected homologous genes from 2 individuals are identical by descent, was calculated by using the genealogy data base of the U tah Mormons.71 They found th a t lip cancer, melanoma and skin cancer had the highest mean kinship coefficient, followed by ovarian, prostate, colon, breast, rectum and blad der cancer. Mean kinship coefficient for bladder cancer was 2.07 X 10 " 5, which was only slightly lower than th at for early onset (younger than 50 years) breast cancer (kinship coeffi cient 2.23 X 10-5). In comparison, mean kinship coefficient for all cancer sites combined was 1.76 X 10" 5 and th a t for a random sample of 3,000 U tah Mormons was 1.40 X 10" 5, which supports familial clustering of bladder cancer. How ever, the methodology is indirect and has many caveats. For example, mean kinship coefficient does not distinguish be tween genetic and environmental causes of familiality. F u r thermore, a fairly large m ean kinship coefficient may origi nate from only 1 or a few related individuals (for example 1 pair of siblings among 150 further unrelated bladder cancer patients would result in a kinship coefficient of 2.25 X 10"5). A later article on the same study population reported th at familiality of bladder cancer was greater among the youngest (less than 6 6 years old) and among female patients.72
Future studies, Analysis of currently available data on familial transitional cell carcinoma is flawed by incomplete data collection, and the complexity inherent in performing epidemiological studies on diseases th a t purportedly result from multifactorial ideologies. In an attem pt to address the issue of familial transitional cell carcinoma, a study to con firm hereditary transitional cell carcinoma is about to begin in The Netherlands th at will address issues, such as extent of transitional cell carcinoma clustering in families, extent to which this clustering is determined by hereditary factors, mode of inheritance of familial transitional cell carcinomas and whether common karyotypic abnormalities exist in tra n s itional cell carcinoma families. In a recent study a family was identified in which the proband had germline translocation of the short arm of chromosome 5 to the long arm of chromo some 20.73 Other members of the family had melanoma and transitional cell carcinoma, raising the possibility th at this translocation may provide additional information about the genetic underpinnings of familial transmission of bladder cancer. A population based case-control study will be con ducted in The N etherlands beginning in 1996 in which 1,000 cases of newly diagnosed transitional cell carcinoma of the bladder, ureter and renal pelvis will be selected from na tional cancer registries. A detailed family history of cancer in first and second degree relatives will be collected from the patients and spouses via a postal questionnaire. Smoking behavior and occupational exposure will be evaluated. For mal cluster and segregation analyses, as well as karyotypic analyses will be performed.
CONCLUSIONS
It is a well accepted fact th at transitional cell carcinoma may cluster in certain cancer family syndromes, such as the Lynch type II (particularly ureter and renal pelvis tumors) and Muir-Torre (lower and upper urinary tract tumors) syn dromes. A large num ber of case reports suggest th a t familial transitional cell carcinoma also exists as a unique entity despite the fact th a t it is difficult to draw firm conclusions from such reports. The causes of this familial clustering as well as its frequency are subject to speculation but a contrib uting genetic cause is likely considering the early age at onset of disease in some families in the literature. The pat tern of occurrence is consistent with autosomal dominant inheritance of a m ajor cancer predisposing gene th at has decreased penetrance. Except for an early age at disease onset, and possibly clustering with other types of tumors, the case reports do not provide any clear indication about poten tial characteristics of fam ilial transitional cell carcinoma (for example multiplicity, stage of disease and prognosis).
Evidence for familial transitional cell carcinoma from epi demiological studies is inconclusive. Studies with small sam ple sizes and those using an indirect approach to evaluate familiality suggest a weak or even absent familial clustering. Large case-control studies, as well as the only study that specifically addresses the issue of familial bladder cancer suggest a familial form of transitional cell carcinoma. 66 Study of hereditary forms of cancers has yielded important clues about the etiology and pathogenesis of sporadic forms of these tumors. For example, the adenomatous polyposis coli gene is m utated in alm ost all colon cancers but was first mapped in pedigrees w ith familial adenomatous polyposis. Furthermore, knowledge of germline mutations may direct early detection of cancer, as is the case in hereditary non polyposis colon cancer and hereditary breast cancer. There fore, it would seem im portant to confirm the existence of a familial subtype of transitional cell carcinoma, and to search for evidence th a t such familial clustering may be caused by specific genes.
